NM_000158.4:c.2053-3358_2053-3350delGTGTGGTGGinsTGTTTTTTACATTACAGGT
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_000158.4(GBE1):c.2053-3358_2053-3350delGTGTGGTGGinsTGTTTTTTACATTACAGGT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 31)
Consequence
GBE1
NM_000158.4 intron
NM_000158.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.749
Publications
0 publications found
Genes affected
GBE1 (HGNC:4180): (1,4-alpha-glucan branching enzyme 1) The protein encoded by this gene is a glycogen branching enzyme that catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on the same or a neighboring glycogen chain. Branching of the chains is essential to increase the solubility of the glycogen molecule and, consequently, in reducing the osmotic pressure within cells. Highest level of this enzyme are found in liver and muscle. Mutations in this gene are associated with glycogen storage disease IV (also known as Andersen's disease). [provided by RefSeq, Jul 2008]
GBE1 Gene-Disease associations (from GenCC):
- glycogen storage disease due to glycogen branching enzyme deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Laboratory for Molecular Medicine, Ambry Genetics, G2P, ClinGen
- adult polyglucosan body diseaseInheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Pathogenic. The variant received 10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-81493813-CCACCACAC-ACCTGTAATGTAAAAAACA is Pathogenic according to our data. Variant chr3-81493813-CCACCACAC-ACCTGTAATGTAAAAAACA is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 2635394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000158.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GBE1 | NM_000158.4 | MANE Select | c.2053-3358_2053-3350delGTGTGGTGGinsTGTTTTTTACATTACAGGT | intron | N/A | NP_000149.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GBE1 | ENST00000429644.7 | TSL:1 MANE Select | c.2053-3358_2053-3350delGTGTGGTGGinsTGTTTTTTACATTACAGGT | intron | N/A | ENSP00000410833.2 | |||
| GBE1 | ENST00000895874.1 | c.2047-3358_2047-3350delGTGTGGTGGinsTGTTTTTTACATTACAGGT | intron | N/A | ENSP00000565933.1 | ||||
| GBE1 | ENST00000942742.1 | c.2047-3358_2047-3350delGTGTGGTGGinsTGTTTTTTACATTACAGGT | intron | N/A | ENSP00000612801.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
ClinVar submissions as Germline
View on ClinVar Significance:Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
1
-
-
GBE1-related disorder (1)
1
-
-
Glycogen storage disease, type IV (1)
1
-
-
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.